Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400089750Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in Maxillofacial Disorders (2 arms), sponsored by Affiliated Stomatological Hospital of Nanjing Medical University. Primary endpoints: Success rate of anesthetic induction and maintenance and Incidence of adverse events. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400089750.